Market Research Logo

Global Travel Vaccines Market 2016-2020

Global Travel Vaccines Market 2016-2020

About Travel Vaccines

As the world continues to move toward globalization, the international travels will keep increasing. This fuels the demand for travel vaccines as the prevalence of infectious diseases are specifically region prone, unlike that of other indications. As vaccines are largely used as a preventive measure against these known infectious diseases, the travelers are advised to follow the region-specific immunization plan. The market is growing because various government bodies have mandated the immunization of travelers visiting the infectious-prone areas with various types of vaccines. This, in turn, prevents the spread of infection and averts any chances of epidemic outbreaks.

Technavio’s analysts forecast the global travel vaccines market to grow at a CAGR of 6.83% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global travel vaccines market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of various vaccines administered to actively immunize meningococcal disease, Japanese encephalitis, rabies, typhoid, yellow fever, hepatitis B, and hepatitis A. The report also considers the revenues to be generated from the sales of vaccines that are expected to be launched into the market during the forecast period.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Travel Vaccines Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
Other prominent vendors
  • Abbott
  • AstraZeneca
  • Bavarian Nordic
  • Baxter
  • Beijing Minhai Biotechnology
  • Bharat Biotech
  • Bharat Immunologicals and Biologicals
  • Bio-Med
  • Seqirus CSL
  • Crucell
  • CSL
  • Dynavax Technologies
  • Emergent BioSolutions
  • GlycoVaxyn
  • GreenSignal Bio Pharma
  • Hualan Biological Engineering
  • Imunoloski Zavod
  • Indian Immunologicals
  • Janssen Pharmaceuticals
  • JN International Medical
  • Kaketsuken
  • LG Life Sciences
  • Lupin
  • Mitsubishi Tanabe Pharma
  • Novavax
  • Nuron Biotech
  • Panacea Biotec
  • Pfizer
  • Protein Sciences
  • Roche
  • SK Chemicals
  • Serum Institute of India
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Takeda Pharmaceutical
  • Vacunas Finlay
  • Valeant Pharmaceuticals
  • Valneva,
  • Zydus Cadila
Market driver
  • Growing demand among travelers
  • For a full, detailed list, view our report
Market challenge
  • Requires specific storage and distribution system
  • For a full, detailed list, view our report
Market trend
  • Combination vaccines
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Travel Vaccines Market 2016-2020

Technavio recognizes the following companies as the key players in the global travel vaccines market: GlaxoSmithKline, Merck, Pfizer, and Sanofi.

Other Prominent Vendors in the market are: Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, and Zydus Cadila.

Commenting on the report, an analyst from Technavio’s team said: “R&D is budding due to a strong need for new efficacious and better tolerated vaccines. The market presents huge growth potential for vendors because of the growing incidence of infectious disease. This requirement is creating a demand for novel vaccines where major players are focusing their R&D efforts and once launched, should become the major growth drivers. Increased investment in R&D by major pharmaceutical companies would fuel the growth of the global travel vaccines market.”

According to the report, the growing demand for vaccines among international travelers is one of the major factors driving the market growth. Many international and national bodies have mandated that the immigrants should be vaccinated before traveling to disease-prone areas. Considering vaccines are largely perceived as a prevention mechanism against the spread of any infectious disease; it is making a specific requirement in international traveler's list.

Further, the report states that vaccines are temperature sensitive in nature and hence, need to be kept under adequately controlled temperature throughout their supply chain. To avoid any loss of potency during its distribution, vaccines need to be kept in 'vaccine cold chain', which includes refrigerators or freezers. Inadequately stored vaccines lose their efficacy to protect against diseases and can lead to increased local reactions.



Companies Mentioned

GlaxoSmithKline, Merck, Pfizer, Sanofi, Abbott, AstraZeneca, Bavarian Nordic, Baxter, Beijing Minhai Biotechnology, Bharat Biotech, Bharat Immunologicals and Biologicals, Bio-Med, Seqirus CSL, Crucell, CSL, Dynavax Technologies, Emergent BioSolutions, GlycoVaxyn, GreenSignal Bio Pharma, Hualan Biological Engineering, Imunoloski Zavod, Indian Immunologicals, Janssen Pharmaceuticals, JN International Medical, Kaketsuken, LG Life Sciences, Lupin, Mitsubishi Tanabe Pharma, Novavax, Nuron Biotech, Panacea Biotec, Pfizer, Protein Sciences, Roche, SK Chemicals, Serum Institute of India, Shenzhen Kangtai Biological Products, Sinovac Biotech, Takeda Pharmaceutical, Vacunas Finlay, Valeant Pharmaceuticals, Valneva, Zydus Cadila.

  • Executive summary
    • Highlights
  • Scope of the report
    • Market overview
    • Top-vendor offerings
      • Table Product offerings
  • Market research methodology
    • Research methodology
    • Economic indicators
  • Introduction
    • Key market highlights
      • Table Market share of travel vaccines markets in global pharmaceutical market 2015
      • Table Market share of travel vaccines markets in global pharmaceutical market, 2015
      • Table Country/region-specific vaccination
      • Table Key buying criteria for travel vaccines 2015
      • Table Impact of key customer segments on market 2015
  • Regulatory scenario of vaccines
    • Table Requirements for a BLA submission
    • Table Stages of vaccine development to obtain license
    • Table Processes involved in the vaccine development
    • Table Regulatory testing of licensed vaccines
  • Market landscape
    • Market overview
      • Table Market snapshot: Global travel vaccines market
      • Table Worldwide endemicity of HAV infection
      • Table Endemicity pattern of HBV across various regions
      • Table Global travel vaccine market snapshot: Developed and emerging markets 2015
      • Table Overview of vaccine-related acquisitions (2005-2012)
      • Table Global travel vaccines market 2015-2020 ($ billions)
      • Table Few of approved travel vaccines
      • Table Vaccine recommendation for travelers
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by disease type
    • Table Market segmentation of travel vaccines based on disease type 2015
    • Table Market share of the different types of travel vaccines based on disease type 2015
    • Table Overview of global travel vaccines market segmentation based on disease type 2015-2020
  • Market segmentation by composition
    • Table Global travel vaccines market segmentation by composition
    • Mono vaccines
      • Table Details of approved polysaccharide vaccines
    • Combination vaccines
  • Geographical segmentation
    • Table Snapshot of global travel vaccines market by geography 2015-2020
    • Table Global travel vaccines market segmentation by geography 2015-2020 ($ millions)
    • Travel vaccines market in Americas
      • Table Overview of travel vaccines market in Americas
      • Table Recommended vaccination for travelers to Mexico
      • Table Recommended vaccination for travelers to Brazil
      • Table Travel vaccines market in Americas 2015-2020 ($ billions)
    • Travel vaccines market in EMEA
      • Table Overview of travel vaccines market in EMEA
      • Table Outbreaks of measles in EMEA during 2011
      • Table Recommended vaccination for travelers to Italy
      • Table Recommended vaccinations for travelers to France
      • Table Recommended vaccinations for some travelers to South Africa
      • Table Travel vaccines market in EMEA 2015-2020 ($ millions)
    • Travel vaccines market in APAC
      • Table Overview of travel vaccines market in APAC
      • Table Recommended vaccination for travelers to India
      • Table Recommended vaccination for travelers to China
      • Table Travel vaccines market in APAC 2015-2020 ($ millions)
  • Market drivers
    • Table Impact of drivers and challenges on global travel vaccines market
    • Growing demand among travelers
    • Additional age group approval
    • Inclusion in NIP
  • Impact of drivers
    • Table Impact of drivers
  • Market challenges
    • Requires specific storage and distribution system
      • Table A typical cold chain process
    • High risk and cost involved in vaccine development
    • Stringent regulatory guidelines
  • Impact of drivers and challenges
    • Table Impact of drivers and challenges
  • Market trends
    • Table Impact of trends on global travel vaccines market
    • Combination vaccines
    • Increase in R&D activities
    • Public-private initiatives
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global travel vaccines market 2015
      • Table Key vendors: Geographical presence 2015
      • Table Competitive assessment of vendors
    • Other prominent vendors
  • Key vendor analysis
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Sanofi
      • Table Sanofi: Key highlights
      • Table Sanofi: Strength assessment
      • Table Sanofi: Strategy assessment
      • Table Sanofi: Opportunity assessment
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report